The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
High‐mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity
Abstract
Summary: Tissue damage occurs often in the life of mammals and is usually repaired. Dying cells are swiftly phagocytosed, but before disappearing, they alert surrounding cells to activate homeostatic programs. They release signals that recruit inflammatory cells to the site of injury, promote cell migration and cell division to replace dead cells, and activate the immune system in anticipation of microbial invasion. Many of these events involve high‐mobility group box 1 protein (HMGB1), a nuclear protein that is released passively when necrotic cells lose the integrity of their membranes. HMGB1 behaves as a trigger of inflammation, attracting inflammatory cells, and of tissue repair, recruiting stem cells and promoting their proliferation. Moreover, HMGB1 activates dendritic cells (DCs) and promotes their functional maturation and their response to lymph node chemokines. Activated leukocytes actively secrete HMGB1 in the microenvironment. Thus, HMGB1 acts in an autocrine/paracrine fashion and sustains long‐term repair and defense programs. DCs secrete HMGB1 several hours after contact with the first maturation stimulus; HMGB1 secretion is critical for their ability to reach the lymph nodes, to sustain the proliferation of antigen‐specific T cells, to prevent their activation‐dependent apoptosis, and to promote their polarization towards a T‐helper 1 phenotype. These immune responses will also be directed against self‐antigens that DCs process at the time of injury and can lead to autoimmunity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, PRR present on or within DC include a group of signaling receptors that stimulate the post uptake reactions (including toll-like receptors, NOD-like receptors, and RIG1-like helicases)52,107.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [52]
In the citing paper
“Similarly, HSPs exposed on or released by tumor cells may act on multiple receptors including CD91, scavenger receptors, TLR2 and TLR4 52.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [52]
In the citing paper
“Thus, HMGB1 may act on the receptor for advanced glycated endproducts (RAGEs) and possibly the toll-like receptors (TLRs) including TLR2 and TLR4 51,52, although the latter are controversial 53.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [52]
Citations
Cites
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221
Self-citationHMG-1 as a Late Mediator of Endotoxin Lethality in Mice
Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L. V., et al. (1999) · Science · doi:10.1126/science.285.5425.248 · Cited by 3,386
Apetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M. C., Ullrich, E., Saulnier, P., et al. (2007) · Nature Medicine · doi:10.1038/nm1622 · Cited by 3,056
DAMPs, PAMPs and alarmins: all we need to know about danger
Bianchi, M. E. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306164 · Cited by 2,794
Self-citationChromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
Leadbetter, E. A., Rifkin, I. R., Hohlbaum, A. M., Beaudette-Zlatanova, B. C., Shlomchik, M. J., & Marshak‐Rothstein, A. (2002) · Nature · doi:10.1038/416603a · Cited by 1,929
Park, J. S., Svetkauskaite, D., He, Q., Kim, J., Strassheim, D., Ishizaka, A., & Abraham, E. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306793200 · Cited by 1,582
Andersson, U., Wang, H., Palmblad, K., Aveberger, A.-C., Bloom, O., Erlandsson-Harris, H., Janson, A., Kokkola, R., Zhang, M., Yang, H., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.4.565 · Cited by 1,401
Tian, J., Avalos, A. M., Mao, S.-Y., Chen, B., Senthil, K., Wu, H., Parroche, P., Drabic, S., Golenbock, D., Sirois, C., et al. (2007) · Nature Immunology · doi:10.1038/ni1457 · Cited by 1,372
Understanding RAGE, the receptor for advanced glycation end products
Bierhaus, A., Humpert, P. M., Morcos, M., Wendt, T., Chavakis, T., Arnold, B., Stern, D. M., & Nawroth, P. P. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0688-7 · Cited by 1,297
Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion
Bonaldi, T., Talamo, F., Scaffidi, P., Ferrera, D., Porto, A., Bachi, A., Rubartelli, A., Agresti, A., & Bianchi, M. E. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg516 · Cited by 1,252
Self-citation
Research works printed but not linked: 1
- Fiuza C, 2002, Inflammatory promoting activity of HMGB1 on human microvascular endothelial cells, Blood, 27, 2652
Cited by
Sorted by citations
Items 401–500 of 600
Chen, Y., Tateda, K., Fujita, K., Ishii, T., Ishii, Y., Kimura, S., Saga, T., Annaka, T., Yamada, S., Zhao, L., et al. (2010) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.11.001 · Cited by 15
Zhang, Y., Liu, Z., Hao, X., Li, A., Zhang, J., Carey, C. D., Falo, L. D., & You, Z. (2017) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-017-2087-7 · Cited by 15
High-mobility-group box chromosomal protein 1 as a new target for modulating stress response
Suda, K., Takeuchi, H., Ishizaka, A., & Kitagawa, Y. (2010) · Surgery Today · doi:10.1007/s00595-009-4232-1 · Cited by 15
Anti-inflammatory action of apoptotic cells in patients with acute coronary syndromes
Ferri, L., Maugeri, N., Rovere, P. Q., Calabrese, A., Ammirati, E., Cianflone, D., Maseri, A., & Manfredi, A. A. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.12.042 · Cited by 14
Self-citationChimenz, R., Chirico, V., Basile, P., Carcione, A. M., Conti, G., Monardo, P., & Lacquaniti, A. (2021) · Journal of Nephrology · doi:10.1007/s40620-021-01015-z · Cited by 14
Cazzato, G., Colagrande, A., Cimmino, A., Cicco, G., Scarcella, V. S., Tarantino, P., Lospalluti, L., Romita, P., Foti, C., Demarco, A., et al. (2021) · Biomolecules · doi:10.3390/biom11081219 · Cited by 14
Mollica, L., Morra, G., Colombo, G., & Musco, G. (2011) · Chemistry - An Asian Journal · doi:10.1002/asia.201000726 · Cited by 14
Zheng, C., Liu, C., Wang, W., Tang, G., Dong, L., Zhou, J., & Zhong, Z. (2016) · PubMed Central · Cited by 14
Jiang, Y., Chen, R., Shao, X., Ji, X., Lu, H., Zhou, S., Zong, G., Xu, H., & Su, Z. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.01.013 · Cited by 14
The role of high mobility group box 1 protein in acute cerebrovascular diseases (Review)
Mu, S., Dang, Y., Wang, S., & Gu, J. (2018) · Biomedical Reports · doi:10.3892/br.2018.1127 · Cited by 14
Allergic Rhinitis in Children: A Randomized Clinical Trial Targeted at Symptoms
Mansi, N., D’Agostino, G., Sciré, A. S., Morpurgo, G., Gregori, D., Gulati, A., & Damiani, V. (2014) · Indian Journal of Otolaryngology and Head & Neck Surgery · doi:10.1007/s12070-014-0708-4 · Cited by 13
Ribeiro, F. S., da Silva, I. C. D. A., Carneiro, V. C., Belgrano, F. S., Mohana‐Borges, R., Rosa, I. D. A., Benchimol, M., Souza, N. R. Q., Mesquita, R. D., Sorgine, M. H. F., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040192 · Cited by 13
Lousberg, E. L., Diener, K. R., Fraser, C. K., Phipps, S., Foster, P. S., Chen, W., Uematsu, S., Akira, S., Robertson, S. A., Brown, M. P., et al. (2011) · Journal of Virology · doi:10.1128/jvi.02000-10 · Cited by 13
Receptor for Advanced Glycation End Products (RAGE) and Its Ligands: Focus on Spinal Cord Injury
Song, J., Lee, W. T., Park, K. H., & Lee, J. E. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150813172 · Cited by 12
MiR-126-HMGB1-HIF-1 Axis Regulates Endothelial Cell Inflammation during Exposure to Hypoxia-Acidosis
Liu, J., Wei, E., Wei, J., Zhou, W., Webster, K. A., Zhang, B., Li, D., Zhang, G., Wei, Y., Long, Y., et al. (2021) · Disease Markers · doi:10.1155/2021/4933194 · Cited by 13
Mirzaei, N. M., Changizi, N., Asadpoure, A., Su, S., Sofia, D., Tatárová, Z., Zervantonakis, I. K., Chang, Y. H., & Shahriyari, L. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1009953 · Cited by 14
Macrophage Genetic Reprogramming During Chronic Peritonitis is Augmented by LPS Pretreatment
Kanaan, Z. M., Gardner, S. M., Carruba, C., Mattingly, J., Druen, D., & Cheadle, W. G. (2011) · Journal of Surgical Research · doi:10.1016/j.jss.2011.04.051 · Cited by 12
Xie, Y., Zhang, K., Zhang, K., Zhang, J., Wang, L., Wang, X., Hu, X., Liang, Z., & Li, J. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29234 · Cited by 11
Second-trimester serum high mobility group box-1 and uterine artery Doppler to predict preeclampsia
Wairachpanich, V., & Phupong, V. (2022) · Scientific Reports · doi:10.1038/s41598-022-10861-1 · Cited by 11
Song, W., Tan, H., Wang, S., Zhang, Y., & Ding, Y. (2018) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2018.0174 · Cited by 12
Encoded novel forms of HSP70 or a cytolytic protein increase DNA vaccine potency
Garrod, T. J., Grubor‐Bauk, B., Yu, W., Gargett, T., & Gowans, E. J. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.29527 · Cited by 12
Velásquez, S., Matute, J. D., Gámez-Díaz, L. Y., Enríquez, L. E., Gómez, I. D., Toro, F., Valencia, M. L., Rosa, G. D. L., Grajales, P. J. P., & Jaimes, F. A. (2013) · Biomédica · doi:10.7705/biomedica.v33i4.805 · Cited by 11
Elsiad, E. A., Aal, H. A. A. E., Salem, H. A., El-Yamany, M. F., & Rabie, M. A. (2025) · Toxics · doi:10.3390/toxics13070594 · Cited by 10
Prasad, S., & Cucullo, L. (2015) · Journal of Pharmacovigilance · doi:10.4172/2329-6887.s2-e003 · Cited by 10
Chen, D., Huang, Y.-H., Chen, Y., Chen, J. J. W., Yang, T.-Y., Chang, G., & Tang, K. (2021) · Lupus Science & Medicine · doi:10.1136/lupus-2021-000562 · Cited by 10
Oncolyic Virotherapy for Prostate Cancer: Lighting a Fire in Winter
Wang, G., Liu, Y., Liu, S., Lin, Y., & Hu, C. P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012647 · Cited by 10
Novel pathways and therapies in experimental diabetic atherosclerosis
Koulis, C., de Haan, J. B., & Allen, T. J. (2012) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.12.13 · Cited by 10
Assessment of HMGB-1 concentration in tick-borne encephalitis and neuroborreliosis
Moniuszko-Malinowska, A. M., Penza, P., Czupryna, P., Zajkowska, O., Pancewicz, S. A., Świerzbińska, R., Dunaj, J., & Zajkowska, J. M. (2018) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2018.03.013 · Cited by 10
Lenka, S. S., Paichha, M., Basu, M., & Samanta, M. (2018) · DNA and Cell Biology · doi:10.1089/dna.2018.4221 · Cited by 10
Zong, Y., Zhang, M., Li, S., Qi, W., Li, J., Liu, T., Yang, H., Chen, L., & Hu, X. (2019) · Gastroenterology Research and Practice · doi:10.1155/2019/2969802 · Cited by 10
Kubota, R., Hayashi, N., Kinoshita, K., Saito, T., Ozaki, K., Ueda, Y., Tsuchishima, M., Tsutsumi, M., & George, J. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15258 · Cited by 10
Nonoxid-HMGB1 Attenuates Cognitive Impairment After Traumatic Brain Injury in Rats
Chen, J.-Q., Gao, S., Luo, L., Jiang, Z., Liang, C., He, H., & Guo, Y. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.827585 · Cited by 10
Low dosages: new chemotherapeutic weapons on the battlefield of immune-related disease
Liu, J., Zhao, J., Hu, L., Cao, Y., & Huang, B. (2011) · Cellular and Molecular Immunology · doi:10.1038/cmi.2011.6 · Cited by 10
John, D., Yuehui, J., Stephen, M., Noakes, P. G., & Woodruff, T. M. (2012) · InTech eBooks · doi:10.5772/30341 · Cited by 10
Rutin mitigates acetic acid-induced ulcerative colitis: novel coloprotective mechanism
Sherif, I. O., Al‐Shaalan, N. H., & Awadin, W. F. (2024) · Toxicology Research · doi:10.1093/toxres/tfae108 · Cited by 9
Targeting glypican-3 as a new frontier in liver cancer therapy
Wu, C.-S., Lee, T.-Y., & Chao, H. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i9.107671 · Cited by 9
He, W., Xu, F., Chen, L., Huang, W. C., Jiang, L., Tang, F., Yan, W., Zhong, S., Shen, C., Huang, H., et al. (2020) · Current Molecular Medicine · doi:10.2174/1566524020666200413113107 · Cited by 9
Gastric alarmin release: A warning signal in the development of gastric mucosal diseases
Wu, E., Zhu, J., Ma, Z., Tuo, B., Terai, S., Mizuno, K., Li, T., & Liu, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1008047 · Cited by 9
Buder, F., Selejan, S., Hohl, M., Kindermann, M., Herr, C., Lepper, P. M., Bals, R., Salzberger, B., Mahfoud, F., & Böhm, M. (2022) · PLoS ONE · doi:10.1371/journal.pone.0275181 · Cited by 9
Decoding the multifaceted roles of galectins in self-defense
Sato, S., Iwaki, J., & Hirabayashi, J. (2024) · Seminars in Immunology · doi:10.1016/j.smim.2024.101926 · Cited by 9
Liu, H., Yao, Y.-M., Ding, L., Zhang, H., Yuan, B., Song, Q., Ye, Q., Huang, C., & Sheng, Z.-Y. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.07.009 · Cited by 9
High Mobility Group Box 1: An Immune-regulatory Protein
Jingjing, Z., Sun, T., Wu, S., & Liu, Y. (2019) · Current Gene Therapy · doi:10.2174/1566523219666190621111604 · Cited by 9
Zaniani, N. R., Roohbakhsh, A., Moghimi, A., & Mehri, S. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113723 · Cited by 9
Modulation of the Wound Healing Response Through Oxidation Active Materials
Wattamwar, P. P., & Dziubla, T. D. (2011) · Springer eBooks · doi:10.1007/978-1-4614-1080-5_7 · Cited by 9
High mobility group box-1 protein – one step closer to the clinic?
Mollnes, T. E. (2008) · Critical Care · doi:10.1186/cc6944 · Cited by 9
Brown, T. A., Tkachuk, A. N., & Clayton, D. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142436 · Cited by 9
An Overview of the Innate Immune Response to Infectious and Noninfectious Stressors
Gallucci, S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801968-9.00001-5 · Cited by 9
Adjuvant role for cell death during chemo- and radiotherapy of cancer?
Rovere, P. Q., & Castiglioni, A. (2007) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.4.1.27 · Cited by 9
Métabolisme du glucose en situation pathologique aiguë
Losser, M.-R., Damoisel, C., & Payen, D. M. (2009) · Annales Françaises d Anesthésie et de Réanimation · doi:10.1016/j.annfar.2009.02.027 · Cited by 9
Emerging Roles of High-mobility Group Box-1 in Liver Disease
Wang, L., Dong, Z., Zhang, Y., & Peng, L. (2024) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2024.00317 · Cited by 8
Perspectives on Populus spp. (Salicaceae) bud extracts as antioxidant and anti-inflammatory agents
Pannucci, E., D’Eliseo, D., Ieri, F., Romani, A., Santi, L., Bernini, R., Sabatti, M., & Velotti, F. (2021) · Natural Product Research · doi:10.1080/14786419.2021.1896512 · Cited by 8
Clinical Analysis and Applications of mRNA Vaccines in Infectious Diseases and Cancer Treatment
Ankrah, P. K., Ilesanmi, A. O., Akinyemi, A. O., Lasehinde, V., Adurosakin, O. E., & Ajayi, O. H. (2023) · Cureus · doi:10.7759/cureus.46354 · Cited by 8
Ancient News: HMGBs are Universal Sentinels
Bianchi, M. E., & Celona, B. (2009) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjp051 · Cited by 8
Self-citationTang, K., Hsieh, T., Chao, Y., Lin, M.-X., Chen, Y., Chen, D.-Y., & Lin, C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178404 · Cited by 8
HMGB1 decreases CCR-2 expression and migration of M2 macrophages under hypoxia
Araya, P., Romero, J. A., Delgado‐López, F., González, I., Añazco, C. C., Pérez-Castro, R., & Armando Rojas, R. (2019) · Inflammation Research · doi:10.1007/s00011-019-01249-5 · Cited by 8
Toll-like receptor triggering in systemic sclerosis: time to target
O’Reilly, S. (2022) · Rheumatology · doi:10.1093/rheumatology/keac421 · Cited by 8
Therapeutic targeting of neuroinflammation in methamphetamine use disorder
Jeffery, N., Mock, P. Y., Yang, K., Tham, C. L., Israf, D. A., Li, H., Wang, X., & Lam, K. W. (2024) · Future Medicinal Chemistry · doi:10.1080/17568919.2024.2447226 · Cited by 7
Vásquez-Suárez, A., Muñoz-Flores, C., Ortega, L., Roa, F. J., Castillo, C., Romero, A., Parra, N. C., Sandoval, F., Macaya, L., González‐Chavarría, I., et al. (2024) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2024.109373 · Cited by 7
Takahata, R., Ono, S., Tsujimoto, H., Hiraki, S., Aosasa, S., Yamamoto, J., & Hase, K. (2014) · Diseases of the Esophagus · doi:10.1111/dote.12261 · Cited by 7
HMGB1 cleavage by complement C1s and its potent anti-inflammatory product
Lorvellec, M., Chouquet, A., Koch, J., Bally, I., Signor, L., Vigne, J., Dalonneau, F., Thielens, N. M., Rabilloud, T., Dalzon, B., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1151731 · Cited by 7
Furukawa, Y., Hayashi, T., Mizuta, M., Ebara, S., Kiku, Y., Ozawa, T., Matsubara, T., Ito, I., Kitamura, D., & Mizuta, R. (2010) · Veterinary Research Communications · doi:10.1007/s11259-010-9454-6 · Cited by 7
Tan, G., Zhu, N., Shi, Z., Meng, Z., Yu, M., Li, K., Yin, J., Wei, K., Mi, X., & Wang, L. (2014) · Scandinavian Journal of Rheumatology · doi:10.3109/03009742.2014.928946 · Cited by 7
Liming, S., Li, G., Wenxin, S., & Guirong, T. (2018) · Experimental Lung Research · doi:10.1080/01902148.2018.1505976 · Cited by 7
Maeda, R., Kawasaki, Y., Kume, Y., Go, H., Suyama, K., & Hosoya, M. (2019) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00263.2019 · Cited by 7
Passàli, D., Bellussi, L. M., Gregori, D., Lauriello, M., Passàli, F. M., & Passàli, G. C. (2012) · Otolaryngologia Polska · doi:10.1016/j.otpol.2012.05.019 · Cited by 7
High Mobility Group Box 1 Ameliorates Cognitive Impairment in the 3×Tg-AD Mouse Model
Zhang, J. C., Hua, X., Gu, J., Chen, F., Gu, J., Gong, C., Liu, F., & Dai, C. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191110 · Cited by 8
Drug resistant epilepsies: A multicentre case series of steroid therapy
Falsaperla, R., Collotta, A. D., Marino, S. D., Sortino, V., Leonardi, R., Privitera, G. F., Pulvirenti, A., Suppiej, A., Vecchi, M., Verrotti, A., et al. (2024) · Seizure · doi:10.1016/j.seizure.2024.02.007 · Cited by 7
Fan, W., Yuan, W., Ding, X., & Zhu, L. (2021) · Virulence · doi:10.1080/21505594.2021.1926409 · Cited by 6
Shao, C., Li, Y., Chen, J., Zheng, L., Chen, W., Peng, Q., Chen, R., & Yuan, A. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2021.732780 · Cited by 6
Recent Aspects of Vasculitis and Future Direction
Aras, G. (2011) · Internal Medicine · doi:10.2169/internalmedicine.50.5459 · Cited by 6
Suda, K., Takeuchi, H., Hagiwara, T., Miyasho, T., Yamada, S., Inoue, T., Okamoto, M., Wada, N., Saikawa, Y., Fukunaga, K., et al. (2010) · ASAIO Journal · doi:10.1097/mat.0b013e3181d68fa4 · Cited by 6
Martínez‐Cabriales, S. A., Gómez‐Flores, M., & Ocampo-Candiani, J. G. (2015) · PubMed · Cited by 6
Cicco, S., Desantis, V., Vacca, A., Cazzato, G., Solimando, A. G., Cirulli, A., Noviello, S., Susca, C., Prete, M., Brosolo, G., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.863150 · Cited by 6
Xu, B., Wen, J., Peng, H.-X., Wang, D., Wen, Z., Liu, Y.-T., Qu, J., Cui, H.-X., Wang, Y.-Y., Du, Y.-L., et al. (2023) · 老年心脏病学杂志:英文版 · doi:10.26599/1671-5411.2023.11.007 · Cited by 6
Appavoo, E., Hajam, I. A., Muneeswaran, N. S., Kondabattula, G., Bhanuprakash, V., & Kishore, S. (2015) · Microbiology and Immunology · doi:10.1111/1348-0421.12350 · Cited by 6
Spleen, as an Optimal Site for Islet Transplantation and a Source of Mesenchymal Stem CellsPreprint
Sakata, N., Yoshimatsu, G., & Kodama, S. (2018) · Preprints.org · doi:10.20944/preprints201802.0101.v2 · Cited by 6
Durgut, B. D., Dilber, B., Kamaşak, T., Yaman, H., Saz, Ö. F., Kolaylı, C. C., Kart, P. Ö., Şahin, S., & Cansu, A. (2025) · Epilepsy Research · doi:10.1016/j.eplepsyres.2025.107553 · Cited by 5
Gao, M., Zhou, J., Shi, N., Yan, X., & Liang, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1742677 · Cited by 5
Khorrami, M., Fadaie, M., Dizaji, S. R., Davoodi, A., Asghari, R., Shen, J., Rahimmanesh, I., Sethi, G., & Makvandi, P. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04286-5 · Cited by 5
Zhang, Y.-J., Huang, C., Zu, X., Liu, J., & Li, Y. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s439315 · Cited by 5
Necroptosis in apical periodontitis: A programmed cell death with multiple roles
Liu, H., Fan, W., & Fan, B. (2023) · Journal of Cellular Physiology · doi:10.1002/jcp.31073 · Cited by 5
HMGB1-TLR Signaling in Rasmussens Encephalitis
Li, T., Gao, Q., & Luan, G. (2016) · Journal of Neuroinfectious Diseases · doi:10.4172/2314-7326.1000223 · Cited by 5
Liu, L., Deng, J., Ji, Q., & Peng, B. (2017) · Journal of Endodontics · doi:10.1016/j.joen.2016.11.014 · Cited by 5
Chen, W., Wei, J., Wang, L., Zhang, D.-W., Tang, W., Wang, J., Yong, Y., Wang, J., Zhou, Y., Yuan, L., et al. (2019) · Trials · doi:10.1186/s13063-019-3889-z · Cited by 5
Khatami, M. (2017) · Springer eBooks · doi:10.1007/978-3-319-66475-0_3 · Cited by 6
Post-translational modifications drive the effects of HMGB1 in alcohol-associated liver disease
Ge, X., Nithyananthan, S., Song, Z., Désert, R., Han, H., Das, S., Komakula, S. S. B., Wang, C., Lantvit, D. D., Ge, Z., et al. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000549 · Cited by 4
Emerging Molecular Mechanisms of Neuroinflammation in Seizure Disorders
Balosso, S., Vezzani, A., & Ravizza, T. (2021) · Progress in inflammation research · doi:10.1007/978-3-030-67403-8_2 · Cited by 4
Could Serum HMGB1 Levels be a Predictor Associated with Psoriatic Arthritis?
Yıldırım, D., Baykul, M., Edek, Y. C., Gülengül, M., Alp, G. T., Eroğlu, F., Adışen, E., Küçük, H., Erden, A., Göker, B., et al. (2023) · Biomarkers in Medicine · doi:10.2217/bmm-2023-0490 · Cited by 4
Tezepelumab: patient selection and place in therapy in severe asthma
Menzella, F., Munari, S., Corsi, L., Tonin, S., Cestaro, W., Ballarin, A., Floriani, A., Dartora, C., & Senna, G. (2024) · Journal of International Medical Research · doi:10.1177/03000605241246740 · Cited by 5
FcγRIIIa Signaling Modulates Endosomal TLR Responses in Human CD4+ T Cells
Chauhan, A. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601954 · Cited by 4
Hubbard, J. A., & Binder, D. K. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802401-0.00013-2 · Cited by 4
Bayoumy, N. M. K., EL-SHABRAWI, M., & NADA3, H. (2013) · Archives of Rheumatology · doi:10.5606/tjr.2013.2845 · Cited by 4
Expression profiles of HMGB1 on B-CLL related leukocytes contribute to prediction of relapse
Schmohl, J. U., Guenther, T., Sutanto, W., Schuster, F. R., Kroell, T., Hartmann, A., Salih, H. R., Stoetzer, O. J., & Schmetzer, H. M. (2020) · Immunobiology · doi:10.1016/j.imbio.2020.152048 · Cited by 4
Gwam, C. U., Emara, A. K., Mohamed, N. S., Chughtai, N., Plate, J. F., & Ma, X. (2021) · Surgical Technology Online · doi:10.52198/21.sti.38.hr1387 · Cited by 4
Sox2 as a servant of two masters
Mankan, A. K., & Hornung, V. (2015) · Nature Immunology · doi:10.1038/ni.3121 · Cited by 4
Protein glycoxidation in neuropsychiatric disorders—from basic research to clinical practice
Orlof, W., & Maciejczyk, M. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104190 · Cited by 3
Damage-associated Molecular Patterns in Clinical and Animal Models of Uveitis
Kaplan, H. J., Sun, D., & Shao, H. (2021) · Ocular Immunology and Inflammation · doi:10.1080/09273948.2021.1954203 · Cited by 3
Abou‐Raya, A., Kamel, M. A. E.-N., Sayed, E. A. G., & El-Sharkawy, A. A. H. (2015) · Alexandria Journal of Medicine · doi:10.1016/j.ajme.2015.06.005 · Cited by 3
Minami, K., Sakaguchi, Y., Yoshida, D., Yamamoto, M., Ikebe, M., Morita, M., & Toh, Y. (2016) · Surgical Case Reports · doi:10.1186/s40792-016-0199-5 · Cited by 3
Sakai, E., & Tsukuba, T. (2014) · Coffee in Health and Disease Prevention · doi:10.1016/b978-0-12-409517-5.00096-6 · Cited by 3
Metadata
- Authors
- Bianchi, M. E., & Manfredi, A. A.
- Affiliations
- Vita-Salute San Raffaele University (IT)
- Corresponding author
- Bianchi, Marco E.
- Venue
- Immunological Reviews
- Publisher
- Wiley
- Published
- 2007-10-30
- Volume
- 220
- Issue
- 1
- Pages
- 35-46
- ISSN
- 0105-2896 (ISSN-L)
- 1600-065X
- OpenAlex
- W2109590683
- Cited by
- 600
- References
- 86
- Citations by year
- 2026: 13 · 2025: 10 · 2024: 13 · 2023: 20 · 2022: 28 · 2021: 21 · 2020: 17 · 2019: 25 · 2018: 41 · 2017: 34 · 2016: 26 · 2015: 37 · 2014: 44 · 2013: 55 · 2012: 45
- FWCI
- 5.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Immunological Reviews (publishedVersion)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Funders
- Associazione Italiana per la Ricerca sul Cancro
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Biomarkers in Disease Mechanisms
- Keywords
- HMGB1, high mobility group box 1, innate immunity, adaptive immunity, inflammation, tissue repair, dendritic cell maturation, T cell activation, autoimmunity, necrosis, chemokines, stem cell recruitment, autocrine and paracrine signaling
- MeSH terms
- Animals, Dendritic Cells, Humans, Immunity, Innate, Lupus Erythematosus, Systemic, T-Lymphocytes, Autoimmunity, Sepsis, HMGB1 Protein, Toll-Like Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review